Harel Insurance Investments & Financial Services Ltd. Eli Lilly & CO Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 406 shares of LLY stock, worth $305,884. This represents 0.01% of its overall portfolio holdings.

Number of Shares

406

Previous 275 47.64%

Holding current value

$305,884

Previous $249,000 44.58%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $101,150 - $125,762	131 Added 47.64%	406 $360,000
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $186,291 - $233,623	-257 Reduced 48.31%	275 $249,000
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $315,050 - $421,492	532 New	532 $414,000
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $262,124 - $361,377	603 New	603 $324,000
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $323,055 - $379,412	1,040 Added 340.98%	1,345 $460,000
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $609,980 - $710,748	-1,897 Reduced 86.15%	305 $112,000
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $534,256 - $608,841	1,802 Added 450.5%	2,202 $727,000
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $1.84 Million - $2.16 Million	-6,600 Reduced 94.29%	400 $130,000
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $1.41 Million - $1.75 Million	-6,000 Reduced 46.15%	7,000 $2.01 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $104,105 - $129,195	-463 Reduced 3.44%	13,000 $3.6 Million
Q3 2021 Oct 25, 2021	BUY	$221.6 - $272.71 $2.51 Million - $3.09 Million	11,329 Added 530.88%	13,463 $3.11 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $90,816 - $117,470	-503 Reduced 19.07%	2,134 $1.6 Million
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $1.54 Million - $1.99 Million	-9,363 Reduced 78.03%	2,637 $1.65 Million
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $5,348 - $7,077	41 Added 0.34%	12,000 $6.52 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $1.7 Million - $1.96 Million	11,596 Added 3194.49%	11,959 $1.77 Million
Q2 2020 Jul 14, 2020	BUY	$136.42 - $164.18 $16,370 - $19,701	120 Added 49.38%	363 $60,000
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $28,929 - $35,806	243 New	243 $34,000
Q4 2019 Jan 23, 2020	SELL	$106.92 - $132.43 $58,806 - $72,836	-550 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $129,109 - $140,437	-1,209 Reduced 68.73%	550 $62,000
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $88,632 - $103,456	800 Added 83.42%	1,759 $195,000
Q1 2019 Apr 18, 2019	SELL	$111.31 - $131.02 $128,117 - $150,804	-1,151 Reduced 54.55%	959 $124,000
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $24,582 - $26,367	300 Added 16.57%	2,110 $178,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $139,496 - $154,827	1,810	1,810 $155,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account

Harel Insurance Investments & Financial Services Ltd. Eli Lilly & CO Transaction History